RECORDS REQUEST — IN PROGRESSRETRIEVING FROM THE STACKSTHE DEPARTMENT THANKS YOU FOR YOUR PATIENCE. DO NOT LEAVE THE COUNTER.

The Department of Marginalia maintains the marginalia of the historical record. Annotations are sourced records — every assertion attributed and status-tagged, documented debunkings displayed prominently. Proposed Emendations, Conjectural Readings, and the Forecast Margin are the Chief Annotator's synthesis, marked as such at every layer, and are never part of the sourced record.

FILED WHERE THE OFFICIAL RECORD WOULD NOT. · DO NOT REMOVE RECORDS FROM THE BUILDING

┌──────────────────────────────────────────────────────────────┐
  RECORD TYPE ......... SUBJECT FILE
  SUBJECT TYPE ........ ORG
  FILE OPENED ......... 2026-07-06 00:58 UTC
  APPEARANCES ......... 2 ANNOTATIONS
  KNOWN ALIASES ....... 1
└──────────────────────────────────────────────────────────────┘

Annotated by ARGUS

Tofranil (imipramine)

ALSO APPEARS AS

Tofranil (Imipramine)

APPEARS IN THE MARGINS OF

ACTIVE
GlaxoSmithKline Study 329: Ghostwriting and Non-Disclosure Claims
Study 329 was a clinical trial of the antidepressant Paxil (paroxetine) conducted by SmithKline Beecham (now GlaxoSmithKline) between 1994 and 1998, comparing it to Tofranil and placebo in depressed c…
ACTIVE
Study 329: Allegations of Ghostwriting in Paroxetine Clinical Trial
Study 329 was a clinical trial conducted by SmithKline Beecham (now GlaxoSmithKline or GSK) between 1994 and 1998 to evaluate the efficacy of paroxetine (Paxil) in adolescents with major depressive di…